314 related articles for article (PubMed ID: 35961704)
1. Patient-derived functional organoids as a personalized approach for drug screening against hepatobiliary cancers.
Li L; Selaru FM
Adv Cancer Res; 2022; 156():319-341. PubMed ID: 35961704
[TBL] [Abstract][Full Text] [Related]
2. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
Pamarthy S; Sabaawy HE
Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
[TBL] [Abstract][Full Text] [Related]
3. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
[TBL] [Abstract][Full Text] [Related]
4. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
Broutier L; Mastrogiovanni G; Verstegen MM; Francies HE; Gavarró LM; Bradshaw CR; Allen GE; Arnes-Benito R; Sidorova O; Gaspersz MP; Georgakopoulos N; Koo BK; Dietmann S; Davies SE; Praseedom RK; Lieshout R; IJzermans JNM; Wigmore SJ; Saeb-Parsy K; Garnett MJ; van der Laan LJ; Huch M
Nat Med; 2017 Dec; 23(12):1424-1435. PubMed ID: 29131160
[TBL] [Abstract][Full Text] [Related]
5. Liver Organoids as an In Vitro Model to Study Primary Liver Cancer.
De Siervi S; Turato C
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901961
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer patient-derived organoids model for the therapeutic drug screening.
Xu J; Gong J; Li M; Kang Y; Ma J; Wang X; Liang X; Qi X; Yu B; Yang J
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130566. PubMed ID: 38244703
[TBL] [Abstract][Full Text] [Related]
7. Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application.
Gao M; Harper MM; Lin M; Qasem SA; Patel RA; Mardini SH; Gabr MM; Cavnar MJ; Pandalai PK; Kim J
J Am Coll Surg; 2021 Apr; 232(4):504-514. PubMed ID: 33253861
[TBL] [Abstract][Full Text] [Related]
8. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
Ren X; Chen W; Yang Q; Li X; Xu L
J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived organoids of non-small cells lung cancer and their application for drug screening.
Li YF; Gao Y; Liang BW; Cao XQ; Sun ZJ; Yu JH; Liu ZD; Han Y
Neoplasma; 2020 Mar; 67(2):430-437. PubMed ID: 31973535
[TBL] [Abstract][Full Text] [Related]
11. Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses.
de Witte CJ; Espejo Valle-Inclan J; Hami N; Lõhmussaar K; Kopper O; Vreuls CPH; Jonges GN; van Diest P; Nguyen L; Clevers H; Kloosterman WP; Cuppen E; Snippert HJG; Zweemer RP; Witteveen PO; Stelloo E
Cell Rep; 2020 Jun; 31(11):107762. PubMed ID: 32553164
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids.
Wang S; Wang Y; Xun X; Zhang C; Xiang X; Cheng Q; Hu S; Li Z; Zhu J
J Exp Clin Cancer Res; 2020 Jan; 39(1):22. PubMed ID: 31992334
[TBL] [Abstract][Full Text] [Related]
13. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
[TBL] [Abstract][Full Text] [Related]
14. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.
Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S
Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
Vlachogiannis G; Hedayat S; Vatsiou A; Jamin Y; Fernández-Mateos J; Khan K; Lampis A; Eason K; Huntingford I; Burke R; Rata M; Koh DM; Tunariu N; Collins D; Hulkki-Wilson S; Ragulan C; Spiteri I; Moorcraft SY; Chau I; Rao S; Watkins D; Fotiadis N; Bali M; Darvish-Damavandi M; Lote H; Eltahir Z; Smyth EC; Begum R; Clarke PA; Hahne JC; Dowsett M; de Bono J; Workman P; Sadanandam A; Fassan M; Sansom OJ; Eccles S; Starling N; Braconi C; Sottoriva A; Robinson SP; Cunningham D; Valeri N
Science; 2018 Feb; 359(6378):920-926. PubMed ID: 29472484
[TBL] [Abstract][Full Text] [Related]
16. Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application.
Ren X; Huang M; Weng W; Xie Y; Wu Y; Zhu S; Zhang Y; Li D; Lai J; Shen S; Lin J; Kuang M; Li X; Yu J; Xu L
Cell Rep Med; 2023 Nov; 4(11):101277. PubMed ID: 37944531
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids.
Amato F; Rae C; Prete MG; Braconi C
Cells; 2020 Mar; 9(4):. PubMed ID: 32235647
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived organoid culture in epithelial ovarian cancers-Techniques, applications, and future perspectives.
Chan WS; Mo X; Ip PPC; Tse KY
Cancer Med; 2023 Oct; 12(19):19714-19731. PubMed ID: 37776168
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary cancers, version 2.2014.
Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
[TBL] [Abstract][Full Text] [Related]
20. Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids.
Wang Z; Guo Y; Jin Y; Zhang X; Geng H; Xie G; Ye D; Yu Y; Liu D; Zhou D; Li B; Luo Y; Peng S; Li J
Cancer Cell Int; 2021 Oct; 21(1):519. PubMed ID: 34600546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
